TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Merck Sharp & Dohme (Sweden) AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,338,135
|
1,541,041
|
1,228,565 |
| Financial expenses |
300
|
346
|
194 |
| Earnings before taxes |
53,981
|
33,405
|
45,434 |
| EBITDA |
40,683
|
17,530
|
44,507 |
| Total assets |
738,428
|
902,700
|
681,893 |
| Current assets |
733,366
|
897,719
|
673,424 |
| Current liabilities |
559,130
|
770,209
|
492,828 |
| Equity capital |
96,511
|
51,233
|
116,936 |
| - share capital |
1,031
|
1,013
|
946 |
| Employees (average) |
126
|
118
|
108 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
13.1%
|
5.7%
|
17.1% |
| Turnover per employee |
10,620
|
13,060
|
11,376 |
| Profit as a percentage of turnover |
4.0%
|
2.2%
|
3.7% |
| Return on assets (ROA) |
7.4%
|
3.7%
|
6.7% |
| Current ratio |
131.2%
|
116.6%
|
136.6% |
| Return on equity (ROE) |
55.9%
|
65.2%
|
38.9% |
| Change turnover |
-230,692
|
225,301
|
65,449 |
| Change turnover % |
-15%
|
17%
|
6% |
| Chg. No. of employees |
8
|
10
|
5 |
| Chg. No. of employees % |
7%
|
9%
|
5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.